Bills › 91st General Assembly

SF 552Died when the session ended · March 6, 2025

Relating to a review of anti-obesity medications by the department of health and human services and the department of administrative services for purposes of the medical assistance program and health insurance plans for state employees

Sponsored by the Senate Health and Human Services Committee

Topics:State governmentHealth careMedicaid

Same legislation: SSB 1138

Where it is now

  1. Done: IntroducedFebruary 18, 2025
  2. Done: SubcommitteeFebruary 18, 2025
  3. Done: Senate committeeMarch 5, 2025
  4. Stopped: Passes the SenateDied when the General Assembly ended
  5. Next: House committeeFunnel: by March 20, 2026
  6. Next: Passes the House
  7. Next: To the Governor
  8. Next: Signed into law

Died when the session ended The 2026 session adjourned on May 3, 2026, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?

What’s in it

AI summary Iowa state agencies will study whether to cover weight-loss drugs, such as GLP-1 agonists, for people on Medicaid or state employee health plans. They will look at how well these medicines work, how much they cost, and who should be allowed to use them. A report with their findings and cost estimates must be given to the state legislature by January 5, 2026.1

Read the official explanation

This bill relates to the department of health and human services (HHS) and the department of administrative services (DAS) review of anti-obesity medication for purposes of the medical assistance program and health insurance plans for state employees established pursuant to Code chapter 509A. The bill requires HHS and DAS to review anti-obesity medications, including GLP-1 agonists, for effectiveness, comorbidities, cost savings, eligibility requirements, and short-term and long-term costs associated with coverage. HHS and DAS shall submit a report to the general assembly by January 5, 2026, containing HHS’s and DAS’s findings, proposed eligibility requirements, and any short-term and long-term costs associated with coverage.

Full bill text2

Senate subcommittee

Named February 18, 2025 (as SSB 1138). On February 20, 2025 it recommended amendment and passage.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Lobbying

2 for · 0 against · 16 undecided · Who →

Family tree